Understanding the regulatory programs enabling cancer stem cells (CSCs) to self-renew and drive tumorigenicity could identify new treatments. Through comparative chromatin state and gene expression analyses in CSCs vs. non-CSCs, we identified FOXK2 as a highly expressed stemness-specific transcription factor (TF). Its genetic depletion diminished stemness features and reduced tumor...